Literature DB >> 31788703

Prevalence of metabolic syndrome in patients with psoriasis: a cross-sectional study in Singapore.

Wai Man Mandy Chan1, Yik Weng Yew1, Thiam Seng Colin Theng2, Choon Fong Liew3, Hazel H Oon1.   

Abstract

INTRODUCTION: Psoriasis is a chronic inflammatory condition that affects the skin and joints, and is associated with cardiovascular risk factors, including metabolic syndrome (MetS). We aimed to assess the prevalence of MetS in patients with psoriasis and determine whether there was a correlation between psoriasis severity and MetS in a Singapore population.
METHODS: This was a cross-sectional study of patients with psoriasis, aged 18-69 years, who attended a tertiary dermatology referral centre in Singapore from October 2007 to February 2009. Fasting glucose, lipids, blood pressure, Psoriasis Area and Severity Index, and body mass index were measured. MetS was diagnosed in the presence of three or more criteria of the modified National Cholesterol Education Program Adult Treatment Panel III.
RESULTS: Among 338 patients with psoriasis, there were 238 (70.4%) men and 100 (29.6%) women, who were Chinese (n = 228; 67.5%), Malay (n = 52; 15.4%) and Indian (n = 58; 17.2%). The prevalence of MetS was 45.1%. MetS was 44% more prevalent in patients older than 50 years (p = 0.02). Malay patients with psoriasis were significantly more likely to have hypertriglyceridaemia, elevated fasting plasma glucose and abdominal obesity. There was no significant correlation between psoriasis severity and risk of MetS.
CONCLUSION: The prevalence of MetS in patients with psoriasis in Singapore was 45.1%, or nearly threefold higher than the Singapore general population. Patients with psoriasis should be screened yearly for MetS and any modifiable cardiovascular risk factors should be actively controlled. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  Singapore; metabolic syndrome; psoriasis

Mesh:

Year:  2019        PMID: 31788703      PMCID: PMC7905140          DOI: 10.11622/smedj.2019152

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  16 in total

1.  Prevalence of metabolic syndrome in Japanese psoriasis patients.

Authors:  Hidetoshi Takahashi; Ichiro Takahashi; Masaru Honma; Akemi Ishida-Yamamoto; Hajime Iizuka
Journal:  J Dermatol Sci       Date:  2009-12-14       Impact factor: 4.563

Review 2.  Relationship between psoriasis and metabolic syndrome: a systematic review.

Authors:  Sanminder Singh; Paulina Young; April W Armstrong
Journal:  G Ital Dermatol Venereol       Date:  2016-09-02       Impact factor: 2.011

3.  Obstacles and solutions to screening psoriasis patients for cardiovascular risk factors.

Authors:  E C E Wang; K J Ker; S Y Chuah; J Y Pan
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-04-26       Impact factor: 6.166

4.  Psoriasis and cardiovascular risk: strength in numbers.

Authors:  Joel M Gelfand; Rahat S Azfar; Nehal N Mehta
Journal:  J Invest Dermatol       Date:  2010-04       Impact factor: 8.551

5.  Risk of myocardial infarction in patients with psoriasis.

Authors:  Joel M Gelfand; Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel
Journal:  JAMA       Date:  2006-10-11       Impact factor: 56.272

6.  Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.

Authors:  Yi-Ju Chen; Chun-Ying Wu; Jui-Lung Shen; Szu-Ying Chu; Chih-Kang Chen; Yun-Ting Chang; Chuan-Mu Chen
Journal:  Arch Dermatol       Date:  2008-12

7.  The risk of stroke in patients with psoriasis.

Authors:  Joel M Gelfand; Erica D Dommasch; Daniel B Shin; Rahat S Azfar; Shanu K Kurd; Xingmei Wang; Andrea B Troxel
Journal:  J Invest Dermatol       Date:  2009-05-21       Impact factor: 8.551

8.  Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.

Authors:  P Gisondi; G Tessari; A Conti; S Piaserico; S Schianchi; A Peserico; A Giannetti; G Girolomoni
Journal:  Br J Dermatol       Date:  2007-06-06       Impact factor: 9.302

Review 9.  Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.

Authors:  April W Armstrong; Caitlin T Harskamp; Ehrin J Armstrong
Journal:  J Am Acad Dermatol       Date:  2013-01-27       Impact factor: 11.527

Review 10.  Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.

Authors:  W Sterry; B E Strober; A Menter
Journal:  Br J Dermatol       Date:  2007-07-11       Impact factor: 9.302

View more
  3 in total

Review 1.  Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management.

Authors:  Eveline De Brandt; Tom Hillary
Journal:  Psoriasis (Auckl)       Date:  2022-05-25

2.  Comorbidity in Men with Psoriasis.

Authors:  Eldina Malkic Salihbegovic; Sadat Kurtalic; Esed Omerkic
Journal:  Med Arch       Date:  2021-02

3.  Metabolic Syndrome and Psoriasis: A Case-Control Study in Kabul, Afghanistan.

Authors:  Ahmad Khalid Aalemi; Mohammad Barin Bahain; Abdul Ghafar Hamdard
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-30       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.